Table 3 Malignant tumors associated with high GLUT5 expression mentioned in this review
|
Cancer |
Expression of GLUT5 |
Influence |
Reference |
|
Colorectal cancer |
Up-regulated |
GLUT5 promotes cancer cell proliferation, migration and invasion, and enhances cancer cell drug resistance. |
|
|
Glioma |
Up-regulated |
GLUT5 is associated with tumor malignancy and poor patient survival. |
|
|
Ovarian cancer |
Up-regulated |
GLUT5 is associated with tumor malignancy and poor patient survival. |
|
|
Lung adenocarcinoma |
Up-regulated |
GLUT5 promotes cancer cell proliferation, migration, invasion and tumorigenicity, enhances cancer cell drug resistance and is associated with poor patient prognosis. |
|
|
Breast cancer |
Up-regulated |
GLUT5 promotes tumor progression. |
|
|
Acute myeloid leukemia |
Up-regulated |
GLUT5 promotes tumor progression. |
|
|
Clear cell renal cell carcinoma |
Up-regulated |
GLUT5 promotes tumor progression. |
|
|
Cholangiocarcinoma |
Up-regulated |
Cancer cells with high GLUT5 expression showed increased cell proliferation and ATP synthesis. |
|
|
Oral squamous cell carcinoma |
Up-regulated |
Up-regulated GLUT5 mediates increased uptake and utilization of fructose by cancer cells induced by IL-6. |
|
|
Prostate cancer |
Up-regulated |
Up-regulated GLUT5 mediates increased uptake and utilization of fructose by cancer cells induced by IL-6. |
|
|
Pancreatic cancer |
Up-regulated |
GLUT5-mediated fructose uptake and utilization promote nucleotide synthesis in cancer cells. |